Exisulind

Exisulind

Download Bissoy App to talk Doctor online

Uses

Investigated for use/treatment in adenomatous polyposis coli, lung cancer, prostate cancer, colon polyps, Barrett's esophagus disease, and pediatric indications.

Download Bissoy App to talk Doctor online

How Exisulind works

Exisulind is a sulindac derivative of a class of compounds called selective apoptotic anti-neoplastic drugs (SAANDs), which inhibit the enzyme cyclic guanosine monophosphodiesterase (cGMP - PDE). Exisulind is specific for apoptotic effects in precancerous and cancerous colorectal cells due to their overexpression of cGMP. Sustained elevation of cGMP and protein kinase G (PKG) activation may be also implicated in the induction of apoptosis by Exisulind.

Exisulind

Trade Name Exisulind
Generic Exisulind
Exisulind Other Names Exisulind, Sulindac sulfone
Type
Formula C20H17FO4S
Weight Average: 372.41
Monoisotopic: 372.083158364
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: August 5, 2021 at 12:40 pm

Structure

Exisulind
Exisulind Structure
Download Bissoy App to talk Doctor online
Download Bissoy App to talk Doctor online
Download Bissoy App to talk Doctor online
Download Bissoy App to talk Doctor online
Download Bissoy App to talk Doctor online
Download Bissoy App to talk Doctor online

Innovators Monograph

You find simplified version here Exisulind